Even geduld alstublieft, we laden de grafiekgegevens
AstraZeneca PLC-community
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is € 168,5, with a 24-hour trading volume of € 83,38M. The asset's market cap is € 261,32B, after moving 1.26% in the last day.
Tokenized AstraZeneca PLC is trading at € 95,91, with a tokenized market cap of € 54,3M and a 24-hour trading volume of € 713,75K. The tokenized asset has moved 2.50% in the past 24 hours.